Development of a CHO cell line for stable production of recombinant antibodies against human MMP9
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ryu, Jina | - |
dc.contributor.author | Kim, Eun-Jung | - |
dc.contributor.author | Kim, Joo-Kyung | - |
dc.contributor.author | Park, Tai Hyun | - |
dc.contributor.author | Kim, Byung-Gee | - |
dc.contributor.author | Jeong, Hee-Jin | - |
dc.date.accessioned | 2022-04-25T07:41:16Z | - |
dc.date.available | 2022-04-25T07:41:16Z | - |
dc.date.created | 2022-04-25 | - |
dc.date.issued | 2022-12-01 | - |
dc.identifier.issn | 1472-6750 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hongik/handle/2020.sw.hongik/27453 | - |
dc.description.abstract | Background Human matrix metalloproteinase 9 (hMMP9) is a biomarker in several diseases, including cancer, and the need for developing detectors and inhibitors of hMMP9 is increasing. As an antibody against hMMP9 can be selectively bound to hMMP9, the use of anti-MMP9 antibody presents new possibilities to address hMMP9-related diseases. In this study, we aimed to establish a stable Chinese hamster ovary (CHO) cell line for the stable production of antibodies against hMMP9. Results Weconstructed recombinant anti-hMMP9 antibody fragment-expressing genes and transfected these to CHO cells. We chose a single clone, and successfully produced a full-sized antibody against hMMP9 with high purity, sensitivity, and reproducibility. Subsequently, we confirmed the antigen-binding efficiency of the antibody. Conclusions We developed a novel recombinant anti-hMMP9 antibody via a CHO cell-based mammalian expression system, which has a high potential to be used in a broad range of medical and industrial areas. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BMC | - |
dc.subject | MONOCLONAL-ANTIBODIES | - |
dc.subject | GELATINASE B | - |
dc.subject | PROTEIN | - |
dc.subject | MATRIX-METALLOPROTEINASE-9 | - |
dc.title | Development of a CHO cell line for stable production of recombinant antibodies against human MMP9 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jeong, Hee-Jin | - |
dc.identifier.doi | 10.1186/s12896-022-00738-6 | - |
dc.identifier.scopusid | 2-s2.0-85125969040 | - |
dc.identifier.wosid | 000765765700002 | - |
dc.identifier.bibliographicCitation | BMC BIOTECHNOLOGY, v.22, no.1 | - |
dc.relation.isPartOf | BMC BIOTECHNOLOGY | - |
dc.citation.title | BMC BIOTECHNOLOGY | - |
dc.citation.volume | 22 | - |
dc.citation.number | 1 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.subject.keywordPlus | MONOCLONAL-ANTIBODIES | - |
dc.subject.keywordPlus | GELATINASE B | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | MATRIX-METALLOPROTEINASE-9 | - |
dc.subject.keywordAuthor | Matrix metalloproteinase 9 | - |
dc.subject.keywordAuthor | Recombinant antibody | - |
dc.subject.keywordAuthor | CHO cell line | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
94, Wausan-ro, Mapo-gu, Seoul, 04066, Korea02-320-1314
COPYRIGHT 2020 HONGIK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.